Publications (106)

2017

  1. Tratado de tecnología farmacéutica dir.

    Síntesis

  2. SEM-image textural features and drug release behavior of Eudragit-based matrix pellets

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 292-298

2016

  1. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets

    International Journal of Pharmaceutics, Vol. 514, Núm. 1, pp. 290-295

  2. Drug structural features affect drug delivery from hyperbranched polyesteramide hot melt extrudates

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 102, pp. 1-8

2015

  1. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization

    Drug Development and Industrial Pharmacy, Vol. 41, Núm. 3, pp. 362-368

  2. Drug dispersion degree and drug dissolution rate in Hybrane S1200-based instant-release matricial particles prepared by hot melt extrusion

    Drug Development and Industrial Pharmacy, Vol. 41, Núm. 6, pp. 1000-1005

  3. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics

    Molecular Pharmaceutics, Vol. 12, Núm. 11, pp. 4077-4084

2014

  1. Evaluation of the hyperbranched polymer Hybrane H1500 for production of matricial controlled-release particles by hot-melt extrusion

    International Journal of Pharmaceutics, Vol. 461, Núm. 1-2, pp. 469-477

2013

  1. Utility of the hyperbranched polymer Hybrane S1200 for production of instant-release particles by hot melt extrusion

    Drug Development and Industrial Pharmacy, Vol. 39, Núm. 7, pp. 1107-1112

  2. Effect of storage conditions on the stability of β-lapachone in solid state and in solution

    Journal of Pharmacy and Pharmacology, Vol. 65, Núm. 6, pp. 798-806

  3. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization

    Pharmaceutical Development and Technology, Vol. 18, Núm. 1, pp. 137-145

2012

  1. Specific considerations on the prescription and therapeutic interchange of statins

    Farmacia Hospitalaria

  2. Seguridad del haba tonka

    Gaceta Sanitaria

  3. Temperature-sensitive gels for intratumoral delivery of β-lapachone: Effect of cyclodextrins and ethanol

    The Scientific World Journal, Vol. 2012

  4. Fast dissolving β-lapachone particles and tablets: An approach using surface adsorption technique

    Drug Development and Industrial Pharmacy, Vol. 38, Núm. 7, pp. 866-871

2011

  1. Review of use of drugs for conditions not included in product characteristics

    Farmacia Hospitalaria

  2. Haba tonka, gin tonic, Sintrom y cocina creativa: a des-propósito de un caso

    Gaceta Sanitaria

  3. Light effect on the stability of β-lapachone in solution: Pathways and kinetics of degradation

    Journal of Pharmacy and Pharmacology, Vol. 63, Núm. 9, pp. 1156-1160

  4. Co-processed MCC-Eudragit® e excipients for extrusion-spheronization

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 79, Núm. 3, pp. 658-663

  5. A comparison of chitosan-silica and sodium starch glycolate as disintegrants for spheronized extruded microcrystalline cellulose pellets

    Drug Development and Industrial Pharmacy, Vol. 37, Núm. 7, pp. 825-831